
Ipsum Pharmaceuticals Private Limited
About Ipsum Pharmaceuticals Private Limited
Data last updated:
Ipsum Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 July 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2012PTC082077. Its GSTIN is 36AADCI1460N1ZF (Telangana).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹47 Lakh. It is led by directors including Palla Aparna and Shyamala Budda.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Plot No 101 & 102A Road No 4 Raghavendra Nagar Bandlaguda Nagole, Hyderabad, Telangana, India – 500068.
As per the financials filed for FY 2021, the company reported a revenue of ₹55.01 Lakh, a decline of 28% compared to the previous year. For the same year it recorded a net profit of ₹1.12 Lakh (net margin 2%) and EBITDA of ₹4.3 Lakh (EBITDA margin 7.8%). Revenue has declined at a compounded annual rate (CAGR) of 22% over three years and 13% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Ipsum Pharmaceuticals has one previous CIN (Corporate Identification Number): U24232AP2012PTC082077. The current CIN is U24232TG2012PTC082077, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2012PTC082077 | Current |
| U24232AP2012PTC082077 | Previous |
Contact details
Ipsum Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No 101 & 102A Road No 4 Raghavendra Nagar Bandlaguda Nagole, Hyderabad, Telangana, India – 500068
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ipsum Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ipsum Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ipsum Pharmaceuticals Private Limited, buy the company report.
Financials of Ipsum Pharmaceuticals Private Limited
FY 2021 filings availableIpsum Pharmaceuticals Private Limited reported revenue of ₹55.01 Lakh (down 28% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 13% over five years, including a 28% fall in the latest year. EBITDA fell 53% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.3 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.12 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.8% | ||||
| Net Profit Margin | 2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ipsum Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ipsum Pharmaceuticals Private Limited
Ipsum Pharmaceuticals has 5 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Palla Aparna | Director | 20 Jul 2012 | 14 Years 4 Months | Current |
| Shyamala Budda | Director | 20 Jul 2012 | 14 Years 4 Months | Current |
| Appala Shashikala | Director | 20 Jul 2012 | 14 Years 4 Months | Current |
| Abhishek Budda Also directs: Desi Goodfoods LLP | Director | 20 Jul 2012 | 14 Years 4 Months | Current |
| Narender Rao Kalakuntla Also directs: Zovalta Pharmaceuticals Private Limited | Director | 20 Jul 2012 | 14 Years 4 Months | Current |
Peer comparison
Ipsum Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Symbiosis Labs Private Limited | ₹55.09 Lakh (FY 2025) | -29.0% | New Delhi, Delhi, India | |||
| Wilfred Pharmaceuticals Private Limited | ₹55.07 Lakh (FY 2025) | 5084.0% | Aurangabad, Maharashtra, India | |||
| Qristol Healthcare Private Limited | ₹55.05 Lakh (FY 2023) | -53.0% | Dehradun, Uttarakhand, India | |||
| Ipsum Pharmaceuticals Private Limitedthis company | ₹55.01 Lakh (FY 2021) | ₹1.12 Lakh | 2% | -28.0% | Hyderabad, Telangana, India | |
| Lift Life Pharmaceuticals Private Limited | ₹54.96 Lakh (FY 2023) | 1.0% | Chandigarh, India | |||
| Synergy Pharmasource Private Limited | ₹54.89 Lakh (FY 2024) | Ahmedabad, Gujarat, India |
To see the full peer comparison of Ipsum Pharmaceuticals Private Limited, buy the company report.
Auditor
Ipsum Pharmaceuticals Private Limited is audited by JANGAM & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JANGAM & ASSOCIATES | FY 2017 | 013288S |
Shareholding
The shareholding of Ipsum Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Ipsum Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ipsum Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ipsum Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ipsum Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCI1460N1ZF | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ipsum Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ipsum Pharmaceuticals Private Limited has 5 board changes on record since 2012: 5 appointments. The latest: Abhishek Budda was appointed as Director on 20 Jul 2012.
Frequently asked questions
Ipsum Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 July 2012 (14+ years old) and is registered under CIN U24232TG2012PTC082077.
Ipsum Pharmaceuticals has 5 current directors:
- Palla Aparna - Director
- Shyamala Budda - Director
- Appala Shashikala - Director
- Abhishek Budda - Director
- Narender Rao Kalakuntla - Director
The latest financial statements of Ipsum Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.
The GSTIN of Ipsum Pharmaceuticals is 36AADCI1460N1ZF, registered in Telangana.
The CIN (Corporate Identification Number) of Ipsum Pharmaceuticals is U24232TG2012PTC082077. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ipsum Pharmaceuticals was incorporated on 20 July 2012, making it 14+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Ipsum Pharmaceuticals by revenue are Symbiosis Labs Private Limited, Wilfred Pharmaceuticals Private Limited, Qristol Healthcare Private Limited, Lift Life Pharmaceuticals Private Limited, Synergy Pharmasource Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Abhishek Budda was appointed as Director on 20 Jul 2012. Appala Shashikala was appointed as Director on 20 Jul 2012. Narender Rao Kalakuntla was appointed as Director on 20 Jul 2012. Ipsum Pharmaceuticals has 5 board changes on record in total.
The registered office of Ipsum Pharmaceuticals is at Plot No 101 & 102A Road No 4 Raghavendra Nagar Bandlaguda Nagole, Hyderabad, Telangana, India – 500068.
Ipsum Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Ipsum Pharmaceuticals is compliant as of 14 August 2026. The company is actively filing with the Registrar of Companies.

